Sign up to save your podcasts
Or
Share FirstWord Pharmaceutical News
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FirstWord Pharmaceutical News
FirstWord Pharmaceutical News episodes
- FirstWord Pharmaceutical News for Monday, October 8 2018Today in FirstWord: Merck & Co., Akcea Therapeutics, Novartis, Lobsor Pharmaceuticals4 min
- FirstWord Pharmaceutical News for Wednesday, September 19 2018Today in FirstWord: GlaxoSmithKline, Novartis, Merck & Co., AbbVie, Clovis Oncology5 min
- FirstWord Pharmaceutical News for Tuesday, September 18 2018Today in FirstWord: Novo Nordisk, Sosei, Allergan, Viking Therapeutics, Almirall, Sun Pharma6 min
- FirstWord Pharmaceutical News for Thursday, September 06 2018Today in FirstWord: Novartis, Aurobindo, Roche, Gilead Sciences, Galapagos, Driver, Civica Rx3 min
- FirstWord Pharmaceutical News for Friday, August 24 2018Today in FirstWord: Shire, AstraZeneca, Merck & Co., China Biologic Products, Pfizer, Kala Pharmaceuticals3 min
- FirstWord Pharmaceutical News for Thursday, August 23 2018Today in FirstWord: Novartis, AstraZeneca, Eisai, Merck & Co., Dompe Farmaceutici3 min
- FirstWord Pharmaceutical News for Wednesday, August 22 2018Today in FirstWord: AbbVie, argenx, Gilead, Sierra Oncology, Novo Nordisk, Evotec, Bristol-Myers Squibb3 min
- FirstWord Pharmaceutical News for Friday, August 17 2018Today in FirstWord: Bristol-Myers Squibb, Novo Nordisk, Ziylo, Regeneron, Roche, Genentech, Eisai, Merck & Co.3 min
- FirstWord Pharmaceutical News for Tuesday, August 14 2018Today in FirstWord: Novartis, Gilead, Biogen, NICE, Sun Pharmaceutical, Realm Therapeutics3 min
- FirstWord Pharmaceutical News for Friday, August 10 2018Today in FirstWord: Alnylam, Amicus Therapeutics, Astellas, Quethera, Gemphire Therapeutics3 min
About FirstWord Pharmaceutical News
From the publisher's feed
Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit…
www.firstwordpharma.com.